Stay updated on Nintedanib vs Placebo in Scleroderma Lung Fibrosis Clinical Trial
Sign up to get notified when there's something new on the Nintedanib vs Placebo in Scleroderma Lung Fibrosis Clinical Trial page.

Latest updates to the Nintedanib vs Placebo in Scleroderma Lung Fibrosis Clinical Trial page
- Check3 days agoChange DetectedThe page's underlying software version was updated from v3.6.0 to v3.6.2, indicating a patch-level release.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page now shows recruitment has ended and adds guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) to aid user navigation. It also reflects a minor header formatting change to Intervention/Treatment and updates the revision tag from v3.5.5 to v3.6.0.SummaryDifference0.1%

- Check24 days agoChange DetectedThe page now shows Revision: v3.5.5, replacing Revision: v3.5.4, indicating an updated version of the page content. It is a metadata update and does not modify the study details.SummaryDifference0.0%

- Check45 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4, indicating a newer version of the site software used to render the ClinicalTrials.gov page. This maintenance update does not modify the study details, eligibility criteria, or results presented on the page.SummaryDifference0.0%

- Check53 days agoChange DetectedA new PubMed-listed publication citation has been added under Publications From PubMed, detailing a substudy related to the SENSCIS trial. This entry connects the trial to additional scholarly work and authors involved.SummaryDifference0.0%

- Check67 days agoChange DetectedThe only visible update is a change in the site’s displayed revision version at the bottom of the page from **v3.5.2** to **v3.5.3**.SummaryDifference0.0%

Stay in the know with updates to Nintedanib vs Placebo in Scleroderma Lung Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nintedanib vs Placebo in Scleroderma Lung Fibrosis Clinical Trial page.